Literature DB >> 33719524

Motor Speech Disorders and Communication Limitations in Progressive Supranuclear Palsy.

Heather M Clark1, Rene L Utianski1, Farwa Ali1, Hugo Botha1, Jennifer L Whitwell2, Keith A Josephs1.   

Abstract

Purpose This study describes motor speech disorders and associated communication limitations in six variants of progressive supranuclear palsy (PSP). Method The presence, nature, and severity of dysarthria and apraxia of speech (AOS) were documented, along with scores on the Apraxia of Speech Rating Scale-Version 3 (ASRS-3) for 77 (40 male and 37 female) patients with PSP. Clinician-estimated and patient-estimated communication limitations were rated using the Motor Speech Disorders Severity Rating (MSDSR) Scale and the Communicative Effectiveness Survey (CES), respectively. Descriptive statistics were calculated for each of these dependent variables. One-tailed t tests were conducted to test mean differences in ASRS-3 and CES between participants with and without AOS and between participants with and without dysarthria. Spearman rank correlations were calculated between ASRS-3 scores and clinical judgments of AOS and dysarthria severity and between MSDSR and CES ratings. Results Nine participants (12%) had normal speech. Eighty-seven percent exhibited dysarthria; hypokinetic and mixed hypokinetic-spastic dysarthria were observed most frequently. AOS was observed in 19.5% of participants across all variants, but in only 10% exclusive of the PSP speech and language variant. Nearly half presented with AOS in which neither phonetic nor prosodic features clearly predominated. The mean ASRS-3 score for participants with AOS was significantly higher than for those without and correlated strongly with clinician judgment of AOS severity. Mean ASRS-3 was higher for participants with dysarthria than for those without but correlated weakly with dysarthria severity. Mean MSDSR and CES ratings were lower in participants with AOS compared to those without and moderately correlated with each other. Conclusions Motor speech disorders that negatively impact communicative effectiveness are common in PSP and occur in many variants. This is the first description of motor speech disorders across PSP variants, setting the stage for future research characterizing neuroanatomical correlates, progression of motor speech disorders, and benefits of targeted interventions. Supplemental Material https://doi.org/10.23641/asha.14111837.

Entities:  

Mesh:

Year:  2021        PMID: 33719524      PMCID: PMC8702836          DOI: 10.1044/2020_AJSLP-20-00126

Source DB:  PubMed          Journal:  Am J Speech Lang Pathol        ISSN: 1058-0360            Impact factor:   2.408


  44 in total

1.  Neuropathologic correlates of dysarthria in progressive supranuclear palsy.

Authors:  K Jellinger
Journal:  Arch Neurol       Date:  2001-09

2.  Differential diagnostic patterns of dysarthria.

Authors:  F L Darley; A E Aronson; J R Brown
Journal:  J Speech Hear Res       Date:  1969-06

Review 3.  Subcortical functions in language: a working model.

Authors:  B Crosson
Journal:  Brain Lang       Date:  1985-07       Impact factor: 2.381

4.  Neuropathological correlates of dysarthria in progressive supranuclear palsy.

Authors:  K Kluin; S Gilman; N Foster; A Sima; C D'Amato; L Bruch; L Bluemlein; R Little; J Johanns
Journal:  Arch Neurol       Date:  2001-02

Review 5.  The diagnosis and understanding of apraxia of speech: why including neurodegenerative etiologies may be important.

Authors:  Joseph R Duffy; Keith A Josephs
Journal:  J Speech Lang Hear Res       Date:  2012-10       Impact factor: 2.297

6.  Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria.

Authors:  S J Collins; J E Ahlskog; J E Parisi; D M Maraganore
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

7.  The Communicative Participation Item Bank (CPIB): item bank calibration and development of a disorder-generic short form.

Authors:  Carolyn Baylor; Kathryn Yorkston; Tanya Eadie; Jiseon Kim; Hyewon Chung; Dagmar Amtmann
Journal:  J Speech Lang Hear Res       Date:  2013-07-01       Impact factor: 2.297

8.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

9.  Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.

Authors:  Jennifer L Whitwell; Nirubol Tosakulwong; Hugo Botha; Farwa Ali; Heather M Clark; Joseph R Duffy; Rene L Utianski; Chase A Stevens; Stephen D Weigand; Christopher G Schwarz; Matthew L Senjem; Clifford R Jack; Val J Lowe; J Eric Ahlskog; Dennis W Dickson; Keith A Josephs
Journal:  Neuroimage Clin       Date:  2019-12-28       Impact factor: 4.881

10.  Communication Limitations in Patients With Progressive Apraxia of Speech and Aphasia.

Authors:  Rene L Utianski; Heather M Clark; Joseph R Duffy; Hugo Botha; Jennifer L Whitwell; Keith A Josephs
Journal:  Am J Speech Lang Pathol       Date:  2020-08-05       Impact factor: 2.408

View more
  2 in total

1.  Depression and Apathy across Different Variants of Progressive Supranuclear Palsy.

Authors:  Sarah M Bower; Stephen D Weigand; Farwa Ali; Heather M Clark; Hugo Botha; Julie A Stierwalt; Jennifer L Whitwell; Keith A Josephs
Journal:  Mov Disord Clin Pract       Date:  2021-12-31

Review 2.  Clinical Spectrum of Tauopathies.

Authors:  Nahid Olfati; Ali Shoeibi; Irene Litvan
Journal:  Front Neurol       Date:  2022-07-14       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.